(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CG FUTURE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CG FUTURE

ST13

US500000078121917

Class

10

Filing

78121917

Registration

2949561

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

06/24/2025

Trademark type

Word

Nice classes

10

Filing date

04/16/2002

Registration date

05/10/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2025

Last transaction

06/24/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/31/2003

First use in commerce

12/31/2003

Drawing code

1

Owner type

03

Owner location

MINNEAPOLIS, MN

Examiner

CLARKE, NANCY

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MEDTRONIC INC.

Representatives

Shane Sondreal MEDTRONIC, INC.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

CARDIAC SURGERY DEVICESANNULOPLASTY RINGS

Publications

History of USPTO decisions and trademark events.

41 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/03/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/03/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/03/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/03/2025

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

05/16/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/01/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

12/04/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/10/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/22/2015

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/22/2015

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/22/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/22/2015

E89R

TEAS SECTION 8 & 9 RECEIVED

05/06/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/29/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/29/2010

E815

TEAS SECTION 8 & 15 RECEIVED

06/10/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

05/10/2005

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

01/25/2005

ALIE

ASSIGNED TO LIE

01/24/2005

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/14/2005

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/14/2005

IUAF

USE AMENDMENT FILED

01/05/2005

EISU

TEAS STATEMENT OF USE RECEIVED

01/05/2005

CFIT

CASE FILE IN TICRS

07/26/2004

EX2G

SOU EXTENSION 2 GRANTED

06/21/2004

EXT2

SOU EXTENSION 2 FILED

06/21/2004

EEXT

SOU TEAS EXTENSION RECEIVED

06/21/2004

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/21/2004

EX1G

SOU EXTENSION 1 GRANTED

02/09/2004

EXT1

SOU EXTENSION 1 FILED

01/09/2004

EEXT

SOU TEAS EXTENSION RECEIVED

01/09/2004

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/15/2003

PUBO

PUBLISHED FOR OPPOSITION

04/22/2003

NPUB

NOTICE OF PUBLICATION

04/02/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/14/2003

CNEA

EXAMINERS AMENDMENT MAILED

02/12/2003

MAIL

PAPER RECEIVED

02/04/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/04/2003

CNRT

NON-FINAL ACTION MAILED

08/06/2002

DOCK

ASSIGNED TO EXAMINER

08/01/2002

Continuous trademark protection

Get notified about every new filing that threatens CG FUTURE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.